Table 1.
Measurement | SCL | CL | CON |
---|---|---|---|
PGI-2 (pg/ml) | 428.32 ± 123.11 | 238.37 ± 174.63 | 496.79 ± 168.10 |
COX-2 (ng/ml) | 34.00 ± 9.13 | 63.91** ± 22.34 | 37.44 ± 13.74 |
HIS (μg/ml) | 4.96** ± 1.19 | 5.47** ± 1.03 | 3.97 ± 0.89 |
IL-1β (ng/ml) | 69.05 ± 22.18 | 60.88 ± 12.66 | 67.48 ± 13.23 |
IL-6 (ng/ml) | 30.56* ± 6.30 | 34.60* ± 5.99 | 25.76 ± 8.84 |
LPS (ng/ml) | 815.07** ± 107.75 | 749.97* ± 192.76 | 684.23 ± 80.53 |
Tnf-α (ng/ml) | 481.61** ± 93.18 | 476.67** ± 58.59 | 387.83 ± 63.15 |
The subclinical group (SCL) and the chronic group (CL) were compared with the healthy group (CON), and there was no comparison between the subclinical group and the chronic group. * indicates that the difference is significant (P < 0.05), and ** indicates that the difference is extremely significant (P < 0.01)